Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-11

Clinical Trial Update: Minimal HePatic Encephalopathy Among CiRrhotics. A Cross SEctional, Clinico-EpidEmiological, Multi-Centre, Study in Patients of PakisTan

View source ↗

Summary

A completed cross-sectional, multicenter study in Pakistan evaluating minimal hepatic encephalopathy in patients with cirrhosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Abbott | Conditions: Hepatic Encephalopathy | Status: COMPLETED